Personalized Decision Making on Genomic Testing in Early Breast Cancer: Expanding the MINDACT Trial with Decision-Analytic Modeling

BACKGROUND: Genomic tests may improve upon clinical risk estimation with traditional prognostic factors. We aimed to explore how evidence on the prognostic strength of a genomic signature (clinical validity) can contribute to individualized decision making on starting chemotherapy for women with bre...

Descripción completa

Detalles Bibliográficos
Autores principales: Steyerberg, Ewout W., de Wreede, Liesbeth C., van Klaveren, David, Bossuyt, Patrick M. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985855/
https://www.ncbi.nlm.nih.gov/pubmed/33655778
http://dx.doi.org/10.1177/0272989X21991173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985855/
https://www.ncbi.nlm.nih.gov/pubmed/33655778
http://dx.doi.org/10.1177/0272989X21991173

Ejemplares similares